{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:03:35Z","timestamp":1785783815028,"version":"3.56.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003792","name":"Brain Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014437","name":"Wenner-Gren Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014437","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004270","name":"Kungliga Tekniska H\u00f6gskolan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018713","name":"Center for Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001388","name":"Wenner-Gren Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001388","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jconrel.2025.114403","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:55:12Z","timestamp":1762833312000},"page":"114403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P2","title":["Bri2 BRICHOS, a molecular chaperone-like domain that can cross brain vascular endothelial cells and deliver proteins into neurons"],"prefix":"10.1016","volume":"388","author":[{"given":"Helene","family":"Tigro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clo\u00e9","family":"Mo\u00eblo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Pelcman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Paslawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gefei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Poska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Shimmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Svenningsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Kronqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jconrel.2025.114403_bb0005","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood-brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114403_bb0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11481-006-9025-3","article-title":"Blood-brain barrier: structural components and function under physiologic and pathologic conditions","volume":"1","author":"Persidsky","year":"2006","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114403_bb0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/17425247.2019.1583205","article-title":"Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology","volume":"16","author":"Moura","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"issue":"18","key":"10.1016\/j.jconrel.2025.114403_bb0020","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1073\/pnas.0702170104","article-title":"Targeted delivery of proteins across the blood-brain barrier","volume":"104","author":"Spencer","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"545","key":"10.1016\/j.jconrel.2025.114403_bb0025","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay1359","article-title":"Brain delivery of therapeutic proteins using an fc fragment blood-brain barrier transport vehicle in mice and monkeys","volume":"12","author":"Kariolis","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114403_bb0030","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/jnc.15768","article-title":"A single-chain fragment constant design enables easy production of a monovalent blood-brain barrier transporter and provides an improved brain uptake at elevated doses","volume":"165","author":"Morrison","year":"2023","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.jconrel.2025.114403_bb0035","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1177\/0271678X18772998","article-title":"A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model","volume":"39","author":"Thom","year":"2019","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jconrel.2025.114403_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.596976","article-title":"Discovery of a highly conserved peptide in the Iron transporter melanotransferrin that traverses an intact blood brain barrier and localizes in neural cells","volume":"15","author":"Singh","year":"2021","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114403_bb0045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13195-023-01236-3","article-title":"Long-term effects of immunotherapy with a brain penetrating Abeta antibody in a mouse model of Alzheimer\u2019s disease","volume":"15","author":"Gustavsson","year":"2023","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.jconrel.2025.114403_bb0050","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1756-0500-2-180","article-title":"BRICHOS - a superfamily of multidomain proteins with diverse functions","volume":"2","author":"Hedlund","year":"2009","journal-title":"BMC. Res. Notes"},{"issue":"7","key":"10.1016\/j.jconrel.2025.114403_bb0055","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0968-0004(02)02134-5","article-title":"BRICHOS: a conserved domain in proteins associated with dementia, respiratory distress and cancer","volume":"27","author":"Sanchez-Pulido","year":"2002","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jconrel.2025.114403_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4645","article-title":"A new kid in the folding funnel: molecular chaperone activities of the BRICHOS domain","volume":"32","author":"Leppert","year":"2023","journal-title":"Protein Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114403_bb0065","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s42003-023-04883-2","article-title":"Short hydrophobic loop motifs in BRICHOS domains determine chaperone activity against amorphous protein aggregation but not against amyloid formation","volume":"6","author":"Chen","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jconrel.2025.114403_bb0070","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1038\/s41467-017-02056-4","article-title":"Bri2 BRICHOS client specificity and chaperone activity are governed by assembly state","volume":"8","author":"Chen","year":"2017","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114403_bb0075","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1021\/acs.biochem.1c00003","article-title":"Smallest secondary nucleation competent Abeta aggregates probed by an ATP-independent molecular chaperone domain","volume":"60","author":"Leppert","year":"2021","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.jconrel.2025.114403_bb0080","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1039\/D2CB00187J","article-title":"Abilities of the BRICHOS domain to prevent neurotoxicity and fibril formation are dependent on a highly conserved asp residue","volume":"3","author":"Chen","year":"2022","journal-title":"RSC Chem. Biol."},{"key":"10.1016\/j.jconrel.2025.114403_bb0085","doi-asserted-by":"crossref","first-page":"E2752","DOI":"10.1073\/pnas.1715951115","article-title":"The BRICHOS domain of Bri2 inhibits islet amyloid polypeptide (IAPP) fibril formation and toxicity in human beta-cells","volume":"115","author":"Oskarsson","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114403_bb0090","doi-asserted-by":"crossref","first-page":"21765","DOI":"10.1038\/s41598-020-78732-1","article-title":"Functionalization of amyloid fibrils via the Bri2 BRICHOS domain","volume":"10","author":"Biverstal","year":"2020","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.jconrel.2025.114403_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/pro.5091","article-title":"Specific inhibition of alpha-synuclein oligomer generation and toxicity by the chaperone domain Bri2 BRICHOS","volume":"33","author":"Adam","year":"2024","journal-title":"Protein Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114403_bb0100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00401-003-0783-1","article-title":"Expression of BRI, the normal precursor of the amyloid protein of familial British dementia, in human brain","volume":"107","author":"Akiyama","year":"2004","journal-title":"Acta Neuropathol."},{"issue":"6738","key":"10.1016\/j.jconrel.2025.114403_bb0105","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/21637","article-title":"A stop-codon mutation in the BRI gene associated with familial British dementia","volume":"399","author":"Vidal","year":"1999","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114403_bb0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1471-4159.2004.02840.x","article-title":"Beta-amyloid protein converting enzyme 1 and brain-specific type II membrane protein BRI3: binding partners processed by furin","volume":"92","author":"Wickham","year":"2005","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114403_bb0115","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1074\/jbc.M706661200","article-title":"Regulated intramembrane proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a\/SPPL2b","volume":"283","author":"Martin","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.jconrel.2025.114403_bb0120","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1074\/jbc.RA118.004538","article-title":"Blood-brain and blood-cerebrospinal fluid passage of BRICHOS domains from two molecular chaperones in mice","volume":"294","author":"Tambaro","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2025.114403_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2020.103498","article-title":"Recombinant BRICHOS chaperone domains delivered to mouse brain parenchyma by focused ultrasound and microbubbles are internalized by hippocampal and cortical neurons","volume":"105","author":"Galan-Acosta","year":"2020","journal-title":"Mol. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114403_bb0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s42003-020-0757-z","article-title":"Augmentation of Bri2 molecular chaperone activity against amyloid-beta reduces neurotoxicity in mouse hippocampus in vitro","volume":"3","author":"Chen","year":"2020","journal-title":"Commun. Biol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114403_bb0135","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ymthe.2022.08.010","article-title":"Intravenous treatment with a molecular chaperone designed against beta-amyloid toxicity improves Alzheimer\u2019s disease pathology in mouse models","volume":"31","author":"Manchanda","year":"2023","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114403_bb0140","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41398-024-03161-x","article-title":"Intravenous chaperone treatment of late-stage Alzheimer s disease (AD) mouse model affects amyloid plaque load, reactive gliosis and AD-related genes","volume":"14","author":"Zhang","year":"2024","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114403_bb0145","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2045-8118-10-16","article-title":"The hCMEC\/D3 cell line as a model of the human blood brain barrier","volume":"10","author":"Weksler","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jconrel.2025.114403_bb0150","doi-asserted-by":"crossref","first-page":"20164","DOI":"10.1038\/srep20164","article-title":"Transthyretin participates in beta-amyloid transport from the brain to the liver--involvement of the low-density lipoprotein receptor-related protein 1?","volume":"6","author":"Alemi","year":"2016","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.jconrel.2025.114403_bb0155","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/jnr.23964","article-title":"Limitations of the hCMEC\/D3 cell line as a model for Abeta clearance by the human blood-brain barrier","volume":"95","author":"Biemans","year":"2017","journal-title":"J. Neurosci. Res."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114403_bb0160","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1471-4159.2008.05730.x","article-title":"The human brain endothelial cell line hCMEC\/D3 as a human blood-brain barrier model for drug transport studies","volume":"107","author":"Poller","year":"2008","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114403_bb0165","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.bbadis.2014.06.029","article-title":"Mixed oligomers and monomeric amyloid-beta disrupts endothelial cells integrity and reduces monomeric amyloid-beta transport across hCMEC\/D3 cell line as an in vitro blood-brain barrier model","volume":"1842","author":"Qosa","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2025.114403_bb0170","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2023.04.020","article-title":"A review on in vitro model of the blood-brain barrier (BBB) based on hCMEC\/D3 cells","volume":"358","author":"Qi","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114403_bb0175","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1073\/pnas.1114740109","article-title":"High-resolution structure of a BRICHOS domain and its implications for anti-amyloid chaperone activity on lung surfactant protein C","volume":"109","author":"Willander","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114403_bb0180","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0149-7634(05)80004-1","article-title":"Insulin in the cerebrospinal fluid","volume":"15","author":"Plata-Salaman","year":"1991","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114403_bb0185","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11095-021-03098-6","article-title":"Interactions of lipids, lipoproteins, and apolipoproteins with the blood-brain barrier","volume":"38","author":"Rhea","year":"2021","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114403_bb0190","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12987-023-00462-z","article-title":"Enhanced in vivo blood brain barrier transcytosis of macromolecular cargo using an engineered pH-sensitive mouse transferrin receptor binding nanobody","volume":"20","author":"Esparza","year":"2023","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jconrel.2025.114403_bb0195","doi-asserted-by":"crossref","first-page":"15504","DOI":"10.1038\/ncomms15504","article-title":"Efficient protein production inspired by how spiders make silk","volume":"8","author":"Kronqvist","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114403_bb0200","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s42003-022-03442-5","article-title":"A spider silk-derived solubility domain inhibits nuclear and cytosolic protein aggregation in human cells","volume":"5","author":"Schellhaus","year":"2022","journal-title":"Commun. Biol."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114403_bb0205","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1034\/j.1600-0854.2001.020301.x","article-title":"Endocytic traffic in polarized epithelial cells: role of the actin and microtubule cytoskeleton","volume":"2","author":"Apodaca","year":"2001","journal-title":"Traffic"},{"issue":"11","key":"10.1016\/j.jconrel.2025.114403_bb0210","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.celrep.2017.11.055","article-title":"Sorting tubules regulate blood-brain barrier transcytosis","volume":"21","author":"Villasenor","year":"2017","journal-title":"Cell Rep."},{"issue":"Pt 2","key":"10.1016\/j.jconrel.2025.114403_bb0215","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1242\/jcs.104.2.521","article-title":"Receptor-mediated endocytosis of transferrin at the blood-brain barrier","volume":"104","author":"Roberts","year":"1993","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114403_bb0220","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac039","article-title":"Syndapin-2 mediated transcytosis of amyloid-beta across the blood-brain barrier","volume":"4","author":"Leite","year":"2022","journal-title":"Brain Commun."},{"issue":"8","key":"10.1016\/j.jconrel.2025.114403_bb0225","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1210\/me.2012-1003","article-title":"Insulin-induced endothelial cell cortical actin filament remodeling: a requirement for trans-endothelial insulin transport","volume":"26","author":"Wang","year":"2012","journal-title":"Mol. Endocrinol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114403_bb0230","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1471-4159.2001.00541.x","article-title":"Restricted transport of anti-transferrin receptor antibody (OX26) through the blood-brain barrier in the rat","volume":"79","author":"Moos","year":"2001","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114403_bb0235","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12934-021-01638-8","article-title":"Expression of the human molecular chaperone domain Bri2 BRICHOS on a gram per liter scale with an E. Coli fed-batch culture","volume":"20","author":"Schmuck","year":"2021","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.jconrel.2025.114403_bb0240","first-page":"1","article-title":"Exosomes: promising delivery tools for overcoming blood-brain barrier and glioblastoma therapy","author":"Khatami","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114403_bb0245","doi-asserted-by":"crossref","first-page":"9817","DOI":"10.1038\/s41598-020-66718-y","article-title":"Recombinant Bri3 BRICHOS domain is a molecular chaperone with effect against amyloid formation and non-fibrillar protein aggregation","volume":"10","author":"Poska","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114403_bb0250","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2202-14-59","article-title":"Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier","volume":"14","author":"Watson","year":"2013","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.jconrel.2025.114403_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105577","article-title":"Human induced pluripotent stem cells (BIONi010-C) generate tight cell monolayers with blood-brain barrier traits and functional expression of large neutral amino acid transporter 1 (SLC7A5)","volume":"156","author":"Goldeman","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114403_bb0260","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00441-014-1810-3","article-title":"Experimental tools to monitor the dynamics of endothelial barrier function: a survey of in vitro approaches","volume":"355","author":"Wegener","year":"2014","journal-title":"Cell Tissue Res."},{"issue":"13","key":"10.1016\/j.jconrel.2025.114403_bb0265","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1096\/fj.04-3458fje","article-title":"Blood-brain barrier-specific properties of a human adult brain endothelial cell line","volume":"19","author":"Weksler","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2025.114403_bb0270","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-1-61779-185-7_24","article-title":"MMP-mediated disruption of claudin-5 in the blood-brain barrier of rat brain after cerebral ischemia","volume":"762","author":"Yang","year":"2011","journal-title":"Methods Mol. Biol."},{"issue":"8","key":"10.1016\/j.jconrel.2025.114403_bb0275","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1021\/bm400898t","article-title":"Morphology and composition of the spider major ampullate gland and dragline silk","volume":"14","author":"Andersson","year":"2013","journal-title":"Biomacromolecules"},{"issue":"10","key":"10.1016\/j.jconrel.2025.114403_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186636","article-title":"In situ fibrillizing amyloid-beta 1-42 induces neurite degeneration and apoptosis of differentiated SH-SY5Y cells","volume":"12","author":"Krishtal","year":"2017","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114403_bb0285","doi-asserted-by":"crossref","first-page":"6949","DOI":"10.1038\/s41598-017-04456-4","article-title":"Modified Western blotting for insulin and other diabetes-associated peptide hormones","volume":"7","author":"Okita","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592501017X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592501017X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T08:53:45Z","timestamp":1780822425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592501017X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":57,"alternative-id":["S016836592501017X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114403","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bri2 BRICHOS, a molecular chaperone-like domain that can cross brain vascular endothelial cells and deliver proteins into neurons","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114403"}}